Biotech Values

[biomaven0]

Any comments on the controlled Phase 2 trial that CLDX is conducting combining rindo + Avastin?

What they are doing makes sense from a theoretical point of view, but who knows how it will work out in practice. I'd put it in the 50:50 bucket. My underlying bias is to view any immune-based therapy as innately uncertain.

Peter